From: Progression of experimental chronic Aleutian mink disease virus infection
Tissue | Score/lesion | Sentinel | Post inoculation week | ||||
---|---|---|---|---|---|---|---|
2 | 4 | 8 | 16 | 24 | |||
Lung | Suspect | – | – | – | – | – | – |
Mild | – | – | 2 | 2/9 | 2/10 | – | |
Moderate | 1 | – | – | – | 2/10 | – | |
Massive | 1 | – | 2 | 2/9 | – | – | |
Total | 2/4 (50 %) | 0/4 | 4/8 (50 %) | 4/9 (44 %) | 4/10 (40 %) | 0/10 | |
Liver | Suspect | – | – | – | 1/9 | 3/9 | 1/9 |
Mild | – | 2 | 2 | 2/9 | 4/9 | 3/9 | |
Moderate | 3 | 2 | 2 | 5/9 | 1/9 | 3/9 | |
Massive | 1 | – | 4 | 1/9 | – | – | |
Total | 4/4 (100 %) | 4/4 (100 %) | 8/8 (100 %) | 9/9 (100 %) | 8/9 (89 %) | 7/9 (78 %) | |
Intestine | Suspect | – | – | – | – | – | – |
Mild | – | – | – | – | – | 1/10 | |
Moderate | 1 | – | – | 3/7 | – | – | |
Massive | – | – | – | – | – | – | |
Total | 1/4 (25 %) | 0/4 | 0/7 | 3/7 (43 %) | 0/10 | 1/10 (10 %) | |
Kidney | Suspect | – | – | – | 1/9 | 3/10 | 2/10 |
Mild | 1 | – | 2 | 2/9 | 1/10 | 2/10 | |
Moderate | – | – | 2 | 2/9 | 1/10 | 2/10 | |
Massive | 3 | – | 2 | 1/9 | 3/10 | – | |
Total | 4/4 (100 %) | 0/4 | 6/8 (75 %) | 6/9 (67 %) | 8/10 (80 %) | 6/10 (60 %) | |
Brain | Suspect | – | – | – | 1/9 | – | – |
Mild | 2 | 1 | 5 | 6/9 | 3/10 | 6/10 | |
Moderate | – | – | – | – | 2/10 | – | |
Massive | – | – | – | – | – | – | |
Total | 2/4 (50 %) | 1/4 (25 %) | 5/8 (63 %) | 7/9 (78 %) | 5/10 (50 %) | 6/10 (60 %) | |
Spleen | LF acta | – | – | 5/8 | 2/9 | 4/10 | – |
LF depb | 3/4 | 3/4 | 1/8 | – | 2/10 | 2/10 | |
Dif. depc | 2/4 | – | 1/8 | 1/9 | 2/10 | 3/10 | |
Stasis | 1/4 | 2/4 | 2/8 | 2/9 | 2/10 | 1/10 | |
Totald | 4/4 (100 %) | 4/4 (100 %) | 8/8 (100 %) | 3/9 (33 %) | 8/10 (80 %) | 4/10 (40 %) | |
Mesenteric lymph node | LF dep | 3/4 | 3/4 | 4/7 | 4/9 | 1/9 | 1/9 |
Plasma cellse | 2/4 | 3/4 | 3/7 | 3/9 | 3/9 | 7/9 | |
Macropf | 2/4 | 1/4 | 3/7 | – | 3/9 | 3/9 | |
Totalg | 4/4 (100 %) | 3/4 (75 %) | 7/7 (100 %) | 6/9 (67 %) | 5/10 (50 %) | 7/9 (78 %) |